Skip to main content

Animations

MJFF Publications

8701 - 8715 of 8715 Results
Title
Year
  • Year
  • 2022
  • 2020
  • 2021
  • 2024
  • 2017
  • 2022
  • 2025
  • 2024
  • 2013
  • 2025
  • 2014
  • 2005
  • 2025
  • 2008
  • 2023
  • Summary Details
    OPEN
    Title: Chronotype, sleep, and sleepiness in Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.10.011
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Prevalence of GBA p.K198E mutation in Colombian and Hispanic populations
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.03.008
    Citation Count: 7
  • Summary Details
    OPEN
    Title: T-cell based immunotherapies for Parkinson’s disease
    Journal Name: Exploration of Neuroprotective Therapy
    Publisher: Open Exploration Publishing
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.37349/ent.2021.00007
    Citation Count: 11
  • Summary Details
    OPEN
    Title: TNF-NF-κB-p53 axis restricts in vivo survival of hPSC-derived dopamine neurons
    Journal Name: Cell
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.cell.2024.05.030
    Citation Count: 19
  • Summary Details
    RESTRICTED
    Title: No evidence for toxicity after long-term photobiomodulation in normal non-human primates
    Journal Name: Experimental Brain Research
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s00221-017-5048-7
    Citation Count: 36
  • Summary Details
    OPEN
    Title: Identifying and characterising sources of variability in digital outcome measures in Parkinson’s disease
    Journal Name: npj Digital Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41746-022-00643-4
    Citation Count: 20
  • Summary Details
    OPEN
    Title: Haploinsufficiency of ITSN1 is associated with a substantial increased risk of Parkinson’s disease
    Journal Name: Cell Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.celrep.2025.115355
    Citation Count: 2
  • Summary Details
    OPEN
    Title: A designed ankyrin-repeat protein that targets Parkinson’s disease-associated LRRK2
    Journal Name: Journal of Biological Chemistry
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.jbc.2024.107469
    Citation Count: 2
  • Summary Details
    OPEN
    Title: The Sac1 Domain of SYNJ 1 Identified Mutated in a Family with Early‐Onset Progressive P arkinsonism with Generalized Seizures
    Journal Name: Human Mutation
    Publisher: Hindawi Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License: unspecified-oa, unspecified-oa
    DOI - Digital Object Identifier: 10.1002/humu.22372
    Citation Count: 315
  • Summary Details
    OPEN
    Title: A cerebrospinal fluid synaptic protein biomarker for prediction of cognitive resilience versus decline in Alzheimer’s disease
    Journal Name: Nature Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd, cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1038/s41591-025-03565-2
    Citation Count: 19
  • Summary Details
    OPEN
    Title: Positive Reinforcement Mediated by Midbrain Dopamine Neurons Requires D1 and D2 Receptor Activation in the Nucleus Accumbens
    Journal Name: PLoS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0094771
    Citation Count: 146
  • Summary Details
    OPEN
    Title: Parkin-deficient mice are not a robust model of parkinsonism
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1073/pnas.0409598102
    Citation Count: 463
  • Summary Details
    RESTRICTED
    Title: Shared and disease-specific pathways in frontotemporal dementia and Alzheimer’s and Parkinson’s diseases
    Journal Name: Nature Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41591-025-03833-1
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Hsp104 antagonizes α-synuclein aggregation and reduces dopaminergic degeneration in a rat model of Parkinson disease
    Journal Name: Journal of Clinical Investigation
    Publisher: American Society for Clinical Investigation
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1172/jci35781
    Citation Count: 195
  • Summary Details
    OPEN
    Title: Using a smartwatch and smartphone to assess early Parkinson’s disease in the WATCH-PD study
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-023-00497-x
    Citation Count: 72
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.